AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Pharmaceutical Investing
NRx Pharmaceuticals to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th Biotech Investing
Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for Advancement of REV102 Program Biotech Investing
Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting Biotech Investing
Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference Biotech Investing
Cidara Therapeutics to Present Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV's 8th AVG and 3rd IMRP 2025 Meeting Biotech Investing
Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference Biotech Investing
Cidara Therapeutics to Present Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV's 8th AVG and 3rd IMRP 2025 Meeting Biotech Investing
Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference Biotech Investing
Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences Biotech Investing
